← Eichor
Condition: Urticaria Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Urticaria

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07408219Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria
Phase 3 · 1 location(s) · Shandong New Time Pharmaceutical Co., LTD · NCT06819774Circadian Rhythm Deregulation in Patients With CAPS
NA · 6 location(s) · Hospices Civils de Lyon · NCT06544018Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria
Phase N/A · 40 location(s) · Bharat Serums and Vaccines Limited · NCT07680413A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity o
Phase 1/Phase 2 · 10 location(s) · Bambusa Therapeutics · NCT07717905Real-life Ecological Momentary Assessment of Lived Burden in Hereditary AngioEdema
Phase N/A · 1 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT07448181A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Phase 2 · 69 location(s) · Pfizer · NCT07219615Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associat
Phase 1 · 1 location(s) · Akros Pharma Inc. · NCT07247266A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urt
Phase 3 · 72 location(s) · Celldex Therapeutics · NCT07266402Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
Phase 1/Phase 2 · 1 location(s) · Institute for Asthma and Allergy · NCT07046806Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
Phase N/A · 6 location(s) · Santé Arménie French-Armenian Research Center · NCT05904301ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
Phase N/A · 1 location(s) · Celltrion HealthCare France · NCT07425639Deep Phenotyping of CIndU
Phase N/A · 3 location(s) · Centre for Human Drug Research, Netherlands · NCT07359430Donidalorsen Treatment in Children With Hereditary Angioedema
Phase 3 · 10 location(s) · Ionis Pharmaceuticals, Inc. · NCT07298447Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-
Phase 2 · 30 location(s) · Yuhan Corporation · NCT07415551A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneou
Phase 3 · 130 location(s) · Novartis Pharmaceuticals · NCT06868212A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria
Phase 1 · 2 location(s) · Granular Therapeutics Limited · NCT07181369Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema
Phase 3 · 32 location(s) · Pharvaris Netherlands B.V. · NCT07266805Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Stil
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT02974595A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of
Phase 1 · 1 location(s) · Enanta Pharmaceuticals, Inc · NCT07540910Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE
Phase 2 · 4 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06919003An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
Phase 2 · 3 location(s) · ARS Pharmaceuticals, Inc. · NCT06927999Comparing Standard-Dose and High-Dose Cetirizine for Acute Urticaria
NA · 1 location(s) · University of Phayao · NCT07236372Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Phase N/A · 10 location(s) · Peter Merkel · NCT03004326Trial to Test the Efficacy of Using Magnetic Fields to Stimulate the Back to Treat Chronic Lower Back Pain.
NA · 1 location(s) · Joe X. Zhang · NCT07652944A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spont
Phase N/A · 1 location(s) · Sanofi · NCT07316114Interleukin-2 for Refractory Chronic Spontaneous Urticaria
Phase 2/Phase 3 · 1 location(s) · Second Xiangya Hospital of Central South University · NCT06924762Remibrutinib in Real-world Clinical Practice
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07358364Institutional Registry of Rare Diseases
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06573723Digital Device Reading Skin Prick Test
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06743737
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.